We initiated a transgenic model for primary pulmonary neuroendocrine cell (PNEC) hyperplasia/neoplasia using v-Ha-ras driven by the neural/neuroendocrine (NE)-speci®c calcitonin promoter (rascal). Previously, we showed that nitrosamine treated rodents develop PNEC hyperplasia but non-NE lung tumors, with variable outcomes presumably re¯ecting ras activation in multiple cell lineages. Interestingly, all rascal transgenic mouse lineages develop hyperplasias of NE and non-NE cells but mostly non-NE lung carcinomas, with rascal mRNA in dierentiated PNECs and tumor cells. Analyses of embryonic lung demonstrate rascal mRNA in undierentiated epithelium, consistent with expression in a common pluripotent precursor cell. These unexpected observations indicate that v-Ha-ras can lead to both NE and non-NE hyperplasia/neoplasia in vivo, opening new avenues for studies of lung carcinogenesis.
Introduction
Using a hamster model of preneoplastic lung injury, we demonstrated that hamsters treated with diethylnitrosamine (DEN) develop PNEC hyperplasia (Sunday and Willett, 1992; Sunday et al., 1994 Sunday et al., , 1995 which re¯ects predominantly cell dierentiation (Sunday et al., 1994) and/or increased cell survival rather than cell proliferation (Willett et al., 1997) . Such hamsters develop only non-NE lung tumors with frequent K-ras mutations (Oreo et al., 1992 (Oreo et al., , 1993 Sunday et al., 1995) , similar to human non-small cell lung carcinomas (NSCLCs) (Slebos et al., 1990) . Human small cell lung carcinomas (SCLCs), NE tumors, are never associated with activated ras (Rodenhuis and Slebos, 1992) .
Our goal was to generate a transgenic animal model of primary PNEC hyperplasia/neoplasia without the widespread non-NE epithelial hyperplasia and non-NE tumors that occur in the hamster nitrosamine models. We generated rascal transgenic mice with v-Ha-ras, which induces PNEC dierentiation (Mabry et al., 1989) , driven by the calcitonin/calcitonin gene-related peptide (CGRP) promoter which has been shown to limit transgene expression to NE and neural cells (Baetscher et al., 1991; Bennett and Amara, 1992) . ras can regulate cellular proliferation and/or cell differentiation (Lowry and Willumsen, 1993) : ras oncogenes are mutated in many human cancers (Barbacid, 1987; Bos, 1989) , and activated ras can transform cells in transgenic mice (Quaife et al., 1987; Mangues et al., 1990) . In vitro, v-Ha-ras can induce dierentiation of neural and NE cell lines along both NE and nonendocrine pathways. In rat PC-12 cells, v-Ha-ras triggered neurite extension (Bar-Sagi and Feramisco, 1985) . In a human medullary thyroid carcinoma (MTC) line, TT, and a classic small cell lung cancer (SCLC) line, DMS53, v-Ha-ras augmented synthesis of calcitonin (a marker of well-dierentiated PNECs) and decreased cell proliferation (Nakagawa et al., 1987; Mabry et al., 1989) . Surprisingly, in a dierent classic SCLC line, H249, v-Ha-ras induced non-NE features (Falco et al., 1990) , supporting the concept that SCLCs and NSCLCs could have direct histogenic links along a common dierentiation pathway in bronchial epithelium Goodwin et al., 1983) .
The phenotype and biological behavior of SCLCs could re¯ect the developmental stage at which tumor cells are arrested. Humans are the only species with naturally occurring SCLCs. Whereas carcinoids arise from well-dierentiated PNECs (Bensch et al., 1965) , few SCLCs express markers of mature PNECs (Bensch et al., 1968; Sunday et al., 1991; Tsutsumi et al., 1983; Gould et al., 1983; Chejfec et al., 1985; Stahlman et al., 1985 Stahlman et al., , 1987 Hamid et al., 1987; Said et al., 1985; Gazdar et al., 1988; Bostwick et al., 1984) , suggesting that SCLCs could be derived from an epithelial stem cell. In the WHO classi®cation, only SCLC and carcinoids are considered to be NE (de Bruine and Bosman, 1990; Paladugu et al., 1985) , but many NSCLCs can express NE markers. Although this observation suggests an inherent plasticity of airway epithelium (Basbaum and Jany, 1990) , it is also consistent with a common lineage for the major forms of lung cancer (Berendsen et al., 1989; Warren et al., 1984; Hammond and Sause, 1985) .
We hypothesized that tri-lineage gene expression by undierentiated epithelium in fetal lung re¯ects the phenotype of a pluripotent precurser cell. Until e15, all undierentiated airway epithelial cells in embryonic lung buds express markers of multiple epithelial cell lineages: CGRP (NE cell marker), SP-A/SP-C (type II cell markers), and CC10 (Clara cell marker) (Wuenschell et al., 1996) . Morphological differentiation subsequently begins *e15 ± 17 for all of these cell types.
Prior evidence suggests that transgenic animals are useful for determining cellular relationships during development. In the lung, transgenic mice carrying a H-2Kb/LacZ fusion gene (Hansbrough et al., 1993) or an SP-C-driven reporter gene (Wert et al., 1993) have been used to study the derivation of alveolar epithelial cells; at *e11, both reporters appear in undifferentiated epithelium, followed by a proximal-to-distal wave of extinction in parallel with cytodierentiation resulting in expression only in the distal-most alveolar cells by birth. These studies suggest there is a common stem cell for the bronchiolar and alveolar cell lineages. Another transgenic mouse bearing a CC10-driven reporter had lineage-speci®c expression in proximal respiratory epithelium (Hackett and Gitlin, 1994) .
Surprisingly, the present study demonstrates that rascal transgenics develop primary lung tumors which are almost exclusively non-NE in phenotype, mostly type II pneumocyte-related, together with hyperplasias of PNECs and Clara cells. These observations provide important information about the probable common histogenesis of diverse pulmonary cell types, supporting the concept of ras oncogene activation in a common precursor cell leading to NE cell dierentiation/ hyperplasia and non-NE cell proliferation/neoplasia.
Results
RT ± PCR and in situ hybridization analyses of rascal transgene expression in normal fetal and non-neoplastic adult lung Five rascal lineages have been derived (Johnston et al., 1998) , all of which express the transgene as both spliced and unspliced mRNA (Figure 1 ). The pair of primers selected ampli®es only the transgene: The 5' primer occurs within the ras p21 and the 3' primer within the SV40 polyadenylation signal (Johnston et al., 1998) . RT ± PCR ampli®cation products are 0.8 and 0.3 kb, with the shorter product corresponding to correctly spliced full length transcript (Johnston et al., 1998) . rascal mRNA levels in lung are lower than in thyroid (*1% of levels in thyroid), with detectable mRNA in whole embryos as early as e12 (Johnston et al., 1998) . In a representative litter at e18, transgene expression occurred in lung from all transgenic pups (A, B, F), but not in normal littermates (C-E) ( Figure  1a ). RT-minus control reactions with the same RNA but lacking reverse transcriptase were negative (unpublished data).
In normal adult lung, rascal is also expressed as both full-length and spliced forms, with some variation in the relative representation of one or both of the bands among transgenic littermates (Figure 1b , lanes 3 and 4). Non-transgenic littermates did not express rascal (lanes 1 and 2). Lung from dierent lineages of transgenic mice (lanes 3 and 4 versus 5) demonstrated similar expression of spliced and full-length rascal mRNAs, and all RT samples contained similar actin mRNA levels.
In situ hybridization using a transgene-speci®c antisense cRNA probe in parallel with CGRP immunostaining demonstrated rascal mRNA in undierentiated CGRP-positive epithelium in e12 fetal lung (Figure 2a and b) . Representative sections from a lineage 2 mouse are presented: CGRP immunostaining was strongest in the most distal undierentiated epithelium (Figure 2a , large arrow at far right) versus moderate levels in the intermediate airways and negative or weak levels in the most proximal airways. A serial section of this same lung probed with rascal antisense cRNA demonstrated rascal mRNA in the most distal undierentiated epithelium, which was most strongly positive for CGRP immunostaining (Figure 2b , far right). The more proximal airway epithelium was devoid of a hybridization signal (Figure 2b, left) . Serial sections hybridized with the corresponding sense cRNA probe were completely negative (Figure 2c ). No rascal mRNA was detected in any normal littermates (data not shown).
At e19, rascal mRNA was detectable in a minority (510%) of CGRP-positive PNECs, exempli®ed by a small cluster of NE cells in a respiratory bronchiole at its junction with an alveolar duct (Figure 2d ). In an immediately serial section (Figure 2e ) a strong rascal hybridization signal is present in the same cluster of Most non-neoplastic adult rascal lung was positive for rascal mRNA by RT ± PCR (Figure 1b ). We were Figure 2 In situ hybridization of fetal and adult rascal lung. 33 P-labeled cRNAs speci®c for only the rascal transgene were hybridized overnight with sections of rascal lung as detailed in Materials and methods. Anti-sense probes are complementary to rascal mRNAs in tissue sections and thus give a positive signal overlying rascal-expressing cells; the sense probe is the negative control, being identical to rascal mRNAs in tissue sections and hence hybridizing only nonspeci®cally. (a ± c) Representative lung sections at e12 from a lineage 2 mouse (6100). The majority of rascal transgenic mice had discrete clusters of CGRP-positive NE cells scattered throughout the airway epithelium, both in bronchioles and in bronchi, consistent with the normal distribution of NE cells in murine lung; these clusters were only slightly raised and frequently formed discrete linear structures ( Figure 3b , between arrows). Only two mice had extensive linear PNEC hyperplasia with 4100 CGRP-positive NE cells/cm ( Figure 3c ). The observed increase in numbers of PNECs in the rascal transgenics is highly signi®cant in spite of some variability in numbers of CGRP-positive cells in the mice (20 ± 119 PNECs/cm airway epithelium in transgenics versus 0 ± 49 in normal littermates).
Most mice expressing the transgene also developed moderate papillary Clara cell hyperplasia (Figure 3e ), in contrast to the single-cell layer of CC10-positive epithelium in normal littermates (Figure 3d ). Note the presence of some CC10-positive immunoreactivity in several alveolar spaces, consistent with secreted CC10 (also known as Clara cell secretory protein).
Characterization of lung tumors in rascal transgenic mice Gross examination of 4500 mice demonstrated 13 primary lung tumors, all cytokeratin-positive, in 255 transgenic mice examined (5.1%), including one undierentiated, one NE, and 11 non-NE (SP-Cpositive) carcinomas (Table 1a) . One additional primary lung tumor was a microscopic adenoma present in one of 370 normal littermate controls (0.25%) examined grossly (80 of which were examined (Figure 6h ) in most tumor cells. Serial sections using thyroglobulin-absorbed antiserum were negative (data not shown). This mouse died at a young age (5 weeks) with major lung histopathology: a glistening, yellowish tumor in®ltrating all lobes (Figure 6a) . Microscopically, the tumor cells contained eosinophilic cytoplasm with cleft-like lamellar inclusions (arrows, Figure  6b ), prominent nucleoli, and cytokeratin-positivity (Figure 6c ). Some tumor cells appeared to bud o from the bronchiolar epithelium at the alveolar ducts (Figure 6d) . The tumor cells were negative for CGRP (Figure 6g ) and mucin, although normal goblet cells occurred in the same lung Three micron sections of paran-embedded tissues were immunostained for CGRP, calcitonin, PGP9.5, surfactant protein C (SPC) or thyroglobulin (TG) as detailed in Materials and methods. Determination of rascal mRNA was carried out using in situ hybridization for tumors I ± VIII, and using RT ± PCR for samples IX ± XV. Mucin was assessed using mucicarmine histochemical staining. Tumor diagnosis was based on histopathological analyses of sections stained with H&E and histochemistry, *Mouse I was found dead and is estimated to have been about 18 h postmortem at the time of harvest. **This was the only tumor that contained focal weak CC10-positive immunostaining within tumor cells. a The only SP-C-positive cells were undierentiated cells at the periphery of the carcinoid tumors (see Figure 7e) (data not shown). This mouse also had a mixed lineage MTC (Figure 6i ± k) which was morphologically distinct from the lung tumor. About 2 ± 5% of the thyroid tumor cells were strongly mucicarmine-positive (Figure 6j arrows), and calcitonin-positive (Figure 6k ), but negative for SP-C and thyroglobulin (data not shown). It should be noted that normal thyroid is not mucin-positive. Thus, the thyroid tumor in mouse VII was dierent from the lung neoplasm, favoring two distinct primaries, or possibly phenotypic divergence following an initial malignant transformation.
(5) One mouse (VIII) had a well-dierentiated NE carcinoma, metastatic throughout both lungs (Figure 7a ), which resembled a carcinoid. The center of the tumor nodules was composed of characteristic nests of small monomorphic NE cells (Figure 7b ,`T' at lower right) immunopositive for cytokeratin (Figure 7c ), PGP9.5 (Figure 7f ), calcitonin and CGRP (data not shown), but negative for thyroglobulin (data not shown) and SP-C (Figure 7e ). A few of these well-dierentiated NE cells were positive for rascal mRNA by in situ hybridization (Figure 7g ). However, there was strong hybridization to a second population of (Figure 7j ), but only infrequent (55%) tumor cells were calcitonin positive (most of which were also PGP9.5-positive, data not shown).
In addition, one transgenic mouse (VI) had an MTC that was distinct from its mixed lineage lung adenocarcinoma. Another mouse (X) had a large melanoma on its back that was distinct from its lung adenocarcinoma. Two mice had metastatic tumors in the lung (Table 1b) : Mouse XIV had metastatic MTC (Johnston et al., 1998) ; mouse XV (lineage I founder) had metastatic lymphoma throughout the lungs and the abdomen.
All lung tumors in rascal transgenic mice were positive for rascal gene expression by in situ hybridization (for mice I ± VII, Figures 6 ± 8) or RT ± PCR analyses (mice IX ± XV).
Discussion
The observation of hyperplasia and malignant lung tumors of diverse epithelial origins in rascal transgenic mice is intriguing, supporting the hypothesis that v-Haras expression in a multipotent stem cell can lead to NE and non-NE cell hyperplasia (dierentiation and/or proliferation) or neoplasia. These data suggest that PNEC hyperplasia and non-NE lung tumors in nitrosamine-treated hamsters might be due to injury to a multipotent stem cell rather than damage to multiple epithelial cell types.
Over 90% of lung tumors in rascal transgenic mice are non-NE, predominantly type II pneumocyte-related (SP-C-positive), suggesting that type II cells and PNECs might be linked along a common lineage determination pathway. Only one mixed-lineage tumor expressed Clara cell antigen CC10 focally. The absence of overt Clara cell tumors could be due to resistance of Clara cells to malignant transformation, similar to PNECs, although Clara cell tumors occur in transgenic mice with TAg driven by the CC10 promoter (De Mayo et al., 1991) . All primary lung tumors were positive for the epithelial marker, cytokeratin, and expressed the rascal transgene at least focally by in situ (Figure 4g ± i) is focally positive for rascal mRNA by in situ hybridization using antisense cRNA probes (bright®eld on left and dark®eld on right), whereas immediately serial sections carried out in parallel using the sense rascal cRNA probe are negative for any hybridization signal (b) (6100) hybridization or RT ± PCR. The focal pattern of transgene expression in many tumors suggests that ras activation might be an initiating event that does not need to be sustained for oncogenesis. However, it is unlikely that activated ras alone is sucient for tumorigenesis. Many mice expressing rascal in lung are tumor free, and most tumors appear with long latency, implying that additional genetic events are necessary to induce lung carcinogenesis: either directly induced by ras, such as genomic instability leading to mutations in tumor suppressor genes (Denko et al., 1994) , or independent events occurring by chance with increasing age. The lack of malignant lung tumors in any normal littermates favors a direct linkage between expression of activated ras and tumorigenesis.
The rascal model for PNEC hyperplasia and diverse lung tumors is unique. Other transgenic murine lung tumor models include: type II cell adenocarcinomas in SP-C-driven SV40 T antigen (Tag) transgenic mice (Wikenheiser and Whitsett, 1997) , Clara cell carcinomas in mice expressing TAg via the uteroglobin promoter (De Mayo et al., 1991; Sandmoller et al., 1995) , lung adenocarcinomas in transgenic mice overexpressing mutant alleles of the p53 oncogene (Lavigueur et al., 1989) , bronchial papillary tumors progressing to lung adenocarcinomas in mice bearing the polyomavirus large T antigen driven by the keratin 19 promoter (Lebel et al., 1995) , and multiple lung tumors in mice expressing an antisense retinoic acid receptor transgene (Berard et al., 1996) .
Several transgenic mouse models have been developed using activated ras oncogenes. Mice carrying mutant forms of a human c-Ha-ras hybrid gene are sensitive to chemically induced lung and forestomach adenocarcinomas (Ogawa et al., 1996) but p21 overexpression was not evident in these tumors suggesting that the mechanism involved mutational activation by ras. Driven by an Ig enhancer and TAg promoter, (6100) activated ras induced lung adenocarcinomas, whereas myc induced pre-B cell lymphomas and TAg induced a variety of tumors (Suda et al., 1987) . Mice with v-Haras driven by the mouse mammary tumor virus long terminal repeat developed bronchoalveolar lung adenocarcinomas and a variety of tumors in other organs (Tremblay et al., 1989) . Finally, a mutated human Ha-ras gene driven by the albumin enhancer/ promoter resulted in multiple alveolar-bronchiolar adenocarcinomas with diversity in tumor morphology suggesting that secondary events contribute to tumor phenotype and behavior (Maronpot et al., 1991) .
The lungs of young rascal transgenic mice are indistinguishable from those of normal littermates at birth, but PNEC hyperplasia becomes evident in most transgenics by 6 ± 12 months of age, also accompanied by Clara cell hyperplasia in over half of the mice. This observation suggests that activated ras can directly induce bronchial epithelial stem cells to undergo terminal dierentiation into PNECs and Clara cells. This interpretation is supported by the rarity of PNEC and Clara cell-derived tumors in rascal transgenics. We have previously demonstrated that PNEC hyperplasia represents predominantly cell dierentiation (Sunday et , 1994) . Similarly, v-Ha-ras induces NE differentiation (increased calcitonin synthesis) and decreased cell proliferation of the classic SCLC cell line DMS53 in vitro (Mabry et al., 1989) .
The lower incidence of lung tumors (*5%) as compared to thyroid tumors (*50 ± 85% in rascal transgenics is believed to be largely due to the lower levels of rascal gene expression (*1 ± 10% rascal mRNA levels in lung versus 100% in thyroid) (Johnston et al., 1998) . It is also likely that dierent secondary genetic events lead to lung carcinomas versus thyroid carcinomas including MTCs: transgenic mice bearing a mutant RET proto-oncogene associated with multiple endocrine neoplasia type 2A develop a high incidence of MTC (Francine-Marie et al., 1997) , and patients with this same mutation do not demonstrate an increased incidence of lung tumors, either NE or non-NE. Also, patients with multiple endocrine neoplasias develop NE tumors in many organs including adrenal, pancreas, parathyroid, thyroid and pituitary, but never lung (Gardner, 1997; Anderson and Lynch, 1997) . Rascal expression could occur in the primitive foregut epithelium destined to become lung and thyroid (also expressing thyroid transcription factor-1 (Lazzaro et al., 1991) which could be a single, shared tumor initiating event leading to independent thyroid and lung primary tumors via ras-induced genomic instability. Subsequent divergence of daughter cells in rascal transgenics is supported by the presence of distinct lung and thyroid neoplasms in several mice. A recent report of undierentiated bronchial carcinoma capable of actively taking up iodine is also consistent with this hypothesis (HauboldReuter et al., 1993) . Furthermore, whereas rascal lineages 2 and 5 both have a relatively high incidence of lung tumors, lineage 2 transgenics have a very low incidence of thyroid tumors (Johnston et al., 1998) , suggesting that the site of transgene integration in this lineage might have disrupted a gene involved in thyroid tumor progression.
A possible mechanism by which rascal could induce diverse epithelial hyperplasias and/or neoplasms invokes the triggering of dierent signal transduction cascades (Margolis and Skolnik, 1994) . ras has been demonstrated to induce both cell proliferation in lung adenocarcinomas (non-NE) and terminal cell differentiation in SCLCs (NE) (Nakagawa et al., 1987; Slebos et al., 1990; Mabry et al., 1989) . Dierent eects of ras have also been observed in distinct hematopoietic cell lineages (Maher et al., 1996) . We demonstrate rascal mRNA in undierentiated epithelium of murine lung at e12 and propose the hypothesis that diverse cellular outcomes could re¯ect the dierentiation pathway selected by each of these cells. Thus, normal and hyperplastic PNECs have a low mitotic rate (Sunday et al., 1994) , and expression of rascal in a NE precursor cell might favor induction of terminal dierentiation, similar to many SCLCs transfected with v-Ha-ras (Mabry et al., 1989; Nakagawa et al., 1987) . We cannot exclude the possibility that the one neuroendocrine lung tumor occurring in transgenic mouse #VIII in the present series of rascal transgenics might represent rare alternative dierentiation of an adenocarcinoma.
Conversely, it appears that the high level of rascal expression in the most distal epithelial cells of embryonic murine lung is linked to the high prevalence of adenocarcinomas expressing the type II cell-speci®c marker, SP-C. Thus, 85% of lung tumors occurring in rascal transgenics appear to be derived from a distal lung epithelial cell precursor. This high prevalence of type II cell tumors is likely to be linked to the greater proliferative capacity of type II cells as opposed to PNECs in rodents (Jones et al., 1985) .
In summary, the present study indicates a lineage relationship between pulmonary NE and non-NE cells. Lineage relationships have been observed only between non-NE cells (type II and Clara cells) in other model systems (Wikenheiser and Whitsett, 1997) . Divergent endocrine-nonendocrine dierentiation is a frequent ®nding in human tumors (Menselsohn and Maksem, 1986) . In SCLC cell line H249, v-Ha-ras induced a NSCLC-like phenotype (Falco et al., 1990) , supporting our observations that the induction of cell differentiation by ras is not always limited exclusively to the NE phenotype, even when a neural/NE -speci®c promoter is used to drive its expression. Furthermore, many SCLCs can undergo non-NE dierentiation spontaneously or following chemotherapy (Brambilla et al., 1991; Saba et al., 1981) . The rascal transgenic mouse model invites further investigation into the whole area of the derivation of lung tumors and the ontogeny of PNECs.
Materials and methods

Transgene analysis
The rascal lineages were prepared on a C57BL/6 x SJL background by DNX, National Transgenic Development Facility (Princeton, NJ, USA) through the National Institutes of Health. For transgene analysis of genomic DNA, the SV40 speci®c fragment of the rascal transgene was used as a probe as described (Johnston et al., 1998) . rascal expression analysis Total lung RNA was isolated using guanidinium isothiocyanate/CsCl (Davis et al., 1986) . RT ± PCR was performed following DNAse treatment of total RNA as described (Johnston et al., 1998) . The primers for ampli®cation of rascal were 695 (forward): 5'-TGCTCCCATTCATCAGTTC-3'; and R8 (reverse): 5'-ACCAAGTCCTTTGAAGACAT-3', Actin ampli®cation was carried out for 20 cycles as described Johnston et al., 1998) . RT ± PCR Southerns were probed with an internal primer corresponding to SV40 polyadenylation sequences found exclusively in the expressed transgene. Negative controls included RNA samples run in parallel except for omission of the reverse transcriptase enzyme (minus RT), and no RNA controls.
Histopathology, antisera and immunohistochemical analyses
Tissues were ®xed overnight in 4% paraformaldehyde in phosphate-buered saline (PBS), then embedded in paran. For routine histopathology, 3 mm paran sections were stained with hematoxylin and eosin (H&E).
Anti-rat calcitonin and CGRP antisera and the corresponding rat peptide antigens were purchased from Peninsula Laboratories (Belmont, CA, USA); anti-human thyroglobulin from Dako Laboratories, Inc. (Santa Barbara, CA, USA); and bovine thyroglobulin for antiserum absorbed controls from Sigma Chemical Co. (St. Louis, MO, USA). Immunohistochemistry was performed using the avidinbiotin complex (ABC) immunoperoxidase technique (Vector Laboratories, Inc., Burlingame, CA, USA) as described (Haley et al., 1997) . Slides were developed using diaminobenzidine and counterstained with 2% methyl green. Control slides used normal rabbit serum or antisera preabsorbed with speci®c antigen: 10 mg/ml of rat calcitonin or CGRP with 1 : 5000 diluted anti-calcitonin or anti-GRP antiserum; and 100 mg/ml of thyroglobulin with 1 : 10 000 diluted antithyroglobulin.
Morphometric analyses
Morphometric analyses were carried out using a Nikon microscope equipped with a drawing arm. A cursor was projected onto the microscope ®eld and the images (1006 magni®cation) were outlined using digitizing pad interfaced with computer-driven morphometry software (SigmaScan, Jandel Scienti®c, San Rafael, CA, USA). Lung sections from 23 mice were randomly picked for computer-assisted morphometry by one investigator (KJ Haley). Basement membrane perimeters of all airways with columnar and/or cuboidal epithelium were measured without knowledge of the tissue genotype. A second investigator (ME Sunday), also blinded to the genotype of the samples, counted all CGRPpositive PNECs, and expressed results as PNECs per centimeter of basement membrane.
Tumors were scored: (+) for 55% of tumor with cytoplasmic staining; (1+) for 5 ± 25% of tumor immunostaining; (2+) for 25 ± 50% immunostaining; and (3+) for 450% of tumor immunostaining.
In situ hybridization In situ hybridization was carried out as described using 33 Plabelled sense and antisense cRNA probes with SV40 polyadenylation signal sequences which are uniquely present in the transgene (Johnston et al., 1998) .
Abbreviations CGRP, calcitonin gene-related peptide; H&E, hematoxylin and eosin; MTC, medullary carcinoma of the thyroid; NE, neuroendocrine; NSCLC, non-small cell lung carcinoma; PBS, phosphate-buered saline; PGP9.5, protein gene product 9.5; PNEC, pulmonary NE cell; RT ± PCR, reverse transcription polymerase chain reaction; SCLC, small cell carcinoma of the lung; Tag, SV40 large T antigen.
